13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 91 holding rows worth $1,083,865,778.
- Accession
- 0001802630-23-000010
- Filer
- CIK 1802630
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 91 entries on the cover page, a total value of $1,083,865,778 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,083,865,778 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 1,250,000 | $91,275,000 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 287,165 | $64,861,959 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 6,052,164 | $61,732,073 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 6,256,784 | $43,922,624 | dollars as filed | |
| Surmodics Inc | 868873100 | Common Stock | 1,230,862 | $39,498,362 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 12,296,163 | $39,101,798 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 943,000 | $34,183,750 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 68,802 | $33,473,549 | dollars as filed | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 628,206 | $27,873,500 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 499,650 | $25,472,157 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 1,907,823 | $25,011,560 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 2,884,382 | $24,113,434 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,466,205 | $23,996,175 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 643,777 | $23,098,719 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,929,019 | $21,720,754 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 127,680 | $20,363,683 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 2,078,000 | $18,992,920 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 3,785,829 | $18,929,145 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 96,064 | $18,826,623 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,056,484 | $18,796,264 | dollars as filed | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 2,806,720 | $16,896,454 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 237,500 | $16,598,875 | dollars as filed | |
| SMITH & NEPHEW PLC SPDN ADR NEW | 83175M205 | ADR | 653,900 | $16,197,103 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 14,803,015 | $15,987,256 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 399,599 | $15,340,606 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 117,892 | $13,675,472 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 642,289 | $13,642,218 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 192,554 | $13,444,120 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 306,000 | $13,402,800 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 4,287,094 | $13,247,120 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 9,677,419 | $12,483,871 | dollars as filed | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 1,408,801 | $11,580,344 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,347,369 | $10,954,110 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 98,000 | $10,646,720 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 549,183 | $10,077,508 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 451,163 | $10,015,819 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 325,000 | $9,590,750 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 384,490 | $9,066,274 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 391,800 | $7,871,262 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 4,356,197 | $7,405,535 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 343,975 | $7,178,758 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 964,550 | $7,137,670 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 154,416 | $7,098,504 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 35,600 | $7,064,464 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 102,196 | $6,971,811 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 814,000 | $6,398,040 | dollars as filed | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 439,000 | $6,062,590 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 8,300,980 | $5,810,686 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,239,777 | $5,640,985 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 344,100 | $5,557,215 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 218,000 | $5,504,500 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 346,033 | $5,342,750 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 372,000 | $5,211,720 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 244,627 | $5,098,027 | dollars as filed | |
| THERATECHNOLOGIES INC | 88338H704 | COM | 2,331,376 | $5,012,458 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 2,692,020 | $5,007,157 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 283,500 | $4,788,315 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,378,128 | $4,506,479 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 250,000 | $4,442,500 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 1,820,983 | $4,333,940 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 103,000 | $3,254,800 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,192,626 | $2,969,639 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 113,800 | $2,959,938 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 781,396 | $2,844,281 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 157,349 | $2,733,152 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 61,377 | $2,715,932 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,025,000 | $2,419,000 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 592,417 | $2,316,350 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 1,150,000 | $1,966,500 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 52,000 | $1,776,320 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 119,500 | $1,735,140 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 333,227 | $1,612,819 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 123,748 | $1,575,312 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 54,400 | $1,523,744 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 122,200 | $1,352,754 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 515,400 | $1,216,344 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 175,000 | $1,109,500 | dollars as filed | |
| AVITA THERAPEUTICS, INC. | 05380C102 | COM | 75,000 | $1,095,750 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 6,440 | $1,088,940 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 104,000 | $1,071,200 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 88,073 | $1,008,436 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 157,182 | $856,642 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 35,000 | $745,500 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 3,900 | $690,690 | dollars as filed | |
| GALECTO INC | 36322Q107 | COM | 897,657 | $645,864 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 144,958 | $587,080 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 150,000 | $567,000 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 304,083 | $565,594 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 226,941 | $478,846 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 300,000 | $441,000 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 12,700 | $404,876 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-23-000010 | this filing | 2023-11-14 | acceptance time not in the bulk data set |